Specific changes and clinical significance of plasma D-dimer during pregnancy and puerperium: a prospective study

Abstract Background Pregnant and puerperal women are high-risk populations for developing venous thromboembolism (VTE). Plasma D-dimer (D-D) is of good value in the diagnosis of exclusion of VTE in the nonpregnant population. Since there is no consensus reference range of plasma D-D applicable to pr...

Full description

Bibliographic Details
Main Authors: Qin Xu, Li Dai, Hong-Qin Chen, Wei Xia, Qi-Lin Wang, Cai-Rong Zhu, Rong Zhou
Format: Article
Language:English
Published: BMC 2023-04-01
Series:BMC Pregnancy and Childbirth
Subjects:
Online Access:https://doi.org/10.1186/s12884-023-05561-1
_version_ 1797845763543269376
author Qin Xu
Li Dai
Hong-Qin Chen
Wei Xia
Qi-Lin Wang
Cai-Rong Zhu
Rong Zhou
author_facet Qin Xu
Li Dai
Hong-Qin Chen
Wei Xia
Qi-Lin Wang
Cai-Rong Zhu
Rong Zhou
author_sort Qin Xu
collection DOAJ
description Abstract Background Pregnant and puerperal women are high-risk populations for developing venous thromboembolism (VTE). Plasma D-dimer (D-D) is of good value in the diagnosis of exclusion of VTE in the nonpregnant population. Since there is no consensus reference range of plasma D-D applicable to pregnant and puerperal women, the application of plasma D-D is limited. To investigate the change characteristics and the reference range of plasma D-D levels during pregnancy and puerperium and to explore the pregnancy- and childbirth-related factors affecting plasma D-D levels and the diagnostic efficacy of plasma D-D for excluding VTE during early puerperium after caesarean section. Methods A prospective cohort study was conducted with 514 pregnant and puerperal women (cohort 1), and 29 puerperal women developed VTE 24–48 h after caesarean section (cohort 2). In cohort 1, the effects of the pregnancy- and childbirth-related factors on the plasma D-D levels were analyzed by comparing the differences in plasma D-D levels between different groups and between different subgroups. The 95th percentiles were calculated to establish the unilateral upper limits of the plasma D-D levels. The plasma D-D levels at 24–48 h postpartum were compared between normal singleton pregnant and puerperal women in cohort 2 and women from the cesarean section subgroup in cohort 1, binary logistic analysis was used to analyze the relevance between plasma D-D level and the risk of VTE developing 24–48 h after caesarean section, and a receiver operating characteristic (ROC) curve was used to assess the diagnostic efficacy of plasma D-D for excluding VTE during early puerperium after caesarean section. Results The 95% reference ranges of plasma D-D levels in the normal singleton pregnancy group were ≤ 1.01 mg/L in the first trimester, ≤ 3.17 mg/L in the second trimester, ≤ 5.35 mg/L in the third trimester, ≤ 5.47 mg/L at 24–48 h postpartum, and ≤ 0.66 mg/L at 42 days postpartum. The plasma D-D levels of the normal twin pregnancy group were significantly higher than those of the normal singleton pregnancy group during pregnancy (P < 0.05), the plasma D-D levels of the GDM group in the third trimester were significantly higher than those of the normal singleton pregnancy group (P < 0.05). The plasma D-D levels of the advanced age subgroup at 24–48 h postpartum were significantly higher than those of the nonadvanced age subgroup (P < 0.05), and the plasma D-D levels of the caesarean section subgroup at 24–48 h postpartum were significantly higher than those of the vaginal delivery subgroup (P < 0.05). The plasma D-D level was significantly correlated with the risk of VTE developing at 24–48 h after caesarean section (OR = 2.252, 95% CI: 1.611–3.149). The optimal cut-off value of plasma D-D for the diagnosis of exclusion of VTE during early puerperium after caesarean section was 3.24 mg/L. The negative predictive value for the diagnosis of exclusion of VTE was 96.1%, and the area under the curve (AUC) was 0.816, P < 0.001. Conclusions The thresholds of plasma D-D levels in normal singleton pregnancy and parturient women were higher than those of nonpregnant women. Plasma D-D had good value in the diagnosis of exclusion of VTE occurring during early puerperium after caesarean section. Further studies are needed to validate these reference ranges and assess the effects of pregnancy- and childbirth-related factors on plasma D-D levels and the diagnostic efficacy of plasma D-D for excluding VTE during pregnancy and puerperium.
first_indexed 2024-04-09T17:44:10Z
format Article
id doaj.art-afc29e9ddf7047a28a16ed9e67b0f242
institution Directory Open Access Journal
issn 1471-2393
language English
last_indexed 2024-04-09T17:44:10Z
publishDate 2023-04-01
publisher BMC
record_format Article
series BMC Pregnancy and Childbirth
spelling doaj.art-afc29e9ddf7047a28a16ed9e67b0f2422023-04-16T11:27:44ZengBMCBMC Pregnancy and Childbirth1471-23932023-04-0123111310.1186/s12884-023-05561-1Specific changes and clinical significance of plasma D-dimer during pregnancy and puerperium: a prospective studyQin Xu0Li Dai1Hong-Qin Chen2Wei Xia3Qi-Lin Wang4Cai-Rong Zhu5Rong Zhou6Department of Obstetrics and Gynecology, Center for Translational Medicine, Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, West China Second University Hospital, Sichuan University; NHC Key Laboratory of Chronobiology, Sichuan UniversityDepartment of Obstetrics and Gynecology, Center for Translational Medicine, Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, West China Second University Hospital, Sichuan University; NHC Key Laboratory of Chronobiology, Sichuan UniversityDepartment of Obstetrics and Gynecology, Center for Translational Medicine, Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, West China Second University Hospital, Sichuan University; NHC Key Laboratory of Chronobiology, Sichuan UniversityDepartment of Obstetrics and Gynecology, Center for Translational Medicine, Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, West China Second University Hospital, Sichuan University; NHC Key Laboratory of Chronobiology, Sichuan UniversityDepartment of Obstetrics and Gynecology, Center for Translational Medicine, Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, West China Second University Hospital, Sichuan University; NHC Key Laboratory of Chronobiology, Sichuan UniversityDepartment of Epidemiology and Health Statistics, West China School of Public Health and West China Fourth Hospital, Sichuan UniversityDepartment of Obstetrics and Gynecology, Center for Translational Medicine, Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, West China Second University Hospital, Sichuan University; NHC Key Laboratory of Chronobiology, Sichuan UniversityAbstract Background Pregnant and puerperal women are high-risk populations for developing venous thromboembolism (VTE). Plasma D-dimer (D-D) is of good value in the diagnosis of exclusion of VTE in the nonpregnant population. Since there is no consensus reference range of plasma D-D applicable to pregnant and puerperal women, the application of plasma D-D is limited. To investigate the change characteristics and the reference range of plasma D-D levels during pregnancy and puerperium and to explore the pregnancy- and childbirth-related factors affecting plasma D-D levels and the diagnostic efficacy of plasma D-D for excluding VTE during early puerperium after caesarean section. Methods A prospective cohort study was conducted with 514 pregnant and puerperal women (cohort 1), and 29 puerperal women developed VTE 24–48 h after caesarean section (cohort 2). In cohort 1, the effects of the pregnancy- and childbirth-related factors on the plasma D-D levels were analyzed by comparing the differences in plasma D-D levels between different groups and between different subgroups. The 95th percentiles were calculated to establish the unilateral upper limits of the plasma D-D levels. The plasma D-D levels at 24–48 h postpartum were compared between normal singleton pregnant and puerperal women in cohort 2 and women from the cesarean section subgroup in cohort 1, binary logistic analysis was used to analyze the relevance between plasma D-D level and the risk of VTE developing 24–48 h after caesarean section, and a receiver operating characteristic (ROC) curve was used to assess the diagnostic efficacy of plasma D-D for excluding VTE during early puerperium after caesarean section. Results The 95% reference ranges of plasma D-D levels in the normal singleton pregnancy group were ≤ 1.01 mg/L in the first trimester, ≤ 3.17 mg/L in the second trimester, ≤ 5.35 mg/L in the third trimester, ≤ 5.47 mg/L at 24–48 h postpartum, and ≤ 0.66 mg/L at 42 days postpartum. The plasma D-D levels of the normal twin pregnancy group were significantly higher than those of the normal singleton pregnancy group during pregnancy (P < 0.05), the plasma D-D levels of the GDM group in the third trimester were significantly higher than those of the normal singleton pregnancy group (P < 0.05). The plasma D-D levels of the advanced age subgroup at 24–48 h postpartum were significantly higher than those of the nonadvanced age subgroup (P < 0.05), and the plasma D-D levels of the caesarean section subgroup at 24–48 h postpartum were significantly higher than those of the vaginal delivery subgroup (P < 0.05). The plasma D-D level was significantly correlated with the risk of VTE developing at 24–48 h after caesarean section (OR = 2.252, 95% CI: 1.611–3.149). The optimal cut-off value of plasma D-D for the diagnosis of exclusion of VTE during early puerperium after caesarean section was 3.24 mg/L. The negative predictive value for the diagnosis of exclusion of VTE was 96.1%, and the area under the curve (AUC) was 0.816, P < 0.001. Conclusions The thresholds of plasma D-D levels in normal singleton pregnancy and parturient women were higher than those of nonpregnant women. Plasma D-D had good value in the diagnosis of exclusion of VTE occurring during early puerperium after caesarean section. Further studies are needed to validate these reference ranges and assess the effects of pregnancy- and childbirth-related factors on plasma D-D levels and the diagnostic efficacy of plasma D-D for excluding VTE during pregnancy and puerperium.https://doi.org/10.1186/s12884-023-05561-1Plasma D-dimerPregnancyPuerperiumReference rangeVenous thromboembolism
spellingShingle Qin Xu
Li Dai
Hong-Qin Chen
Wei Xia
Qi-Lin Wang
Cai-Rong Zhu
Rong Zhou
Specific changes and clinical significance of plasma D-dimer during pregnancy and puerperium: a prospective study
BMC Pregnancy and Childbirth
Plasma D-dimer
Pregnancy
Puerperium
Reference range
Venous thromboembolism
title Specific changes and clinical significance of plasma D-dimer during pregnancy and puerperium: a prospective study
title_full Specific changes and clinical significance of plasma D-dimer during pregnancy and puerperium: a prospective study
title_fullStr Specific changes and clinical significance of plasma D-dimer during pregnancy and puerperium: a prospective study
title_full_unstemmed Specific changes and clinical significance of plasma D-dimer during pregnancy and puerperium: a prospective study
title_short Specific changes and clinical significance of plasma D-dimer during pregnancy and puerperium: a prospective study
title_sort specific changes and clinical significance of plasma d dimer during pregnancy and puerperium a prospective study
topic Plasma D-dimer
Pregnancy
Puerperium
Reference range
Venous thromboembolism
url https://doi.org/10.1186/s12884-023-05561-1
work_keys_str_mv AT qinxu specificchangesandclinicalsignificanceofplasmaddimerduringpregnancyandpuerperiumaprospectivestudy
AT lidai specificchangesandclinicalsignificanceofplasmaddimerduringpregnancyandpuerperiumaprospectivestudy
AT hongqinchen specificchangesandclinicalsignificanceofplasmaddimerduringpregnancyandpuerperiumaprospectivestudy
AT weixia specificchangesandclinicalsignificanceofplasmaddimerduringpregnancyandpuerperiumaprospectivestudy
AT qilinwang specificchangesandclinicalsignificanceofplasmaddimerduringpregnancyandpuerperiumaprospectivestudy
AT cairongzhu specificchangesandclinicalsignificanceofplasmaddimerduringpregnancyandpuerperiumaprospectivestudy
AT rongzhou specificchangesandclinicalsignificanceofplasmaddimerduringpregnancyandpuerperiumaprospectivestudy